Canta Medical exhibits at WHX DUBAI 2026

Innovative Technology, Serving the World | Canta Medical Showcases at WHX DUBAI 2026

From February 9 to 12, 2026, the 51st World Healthcare Exhibition (Dubai) was held in the United Arab Emirates, bringing together over 4,000 exhibitors from more than 160 countries and attracting more than 120,000 visitors.

Multiple Products Debut in the Middle East, Precisely Meeting Regional Needs

Canta Medical was invited to exhibit a series of flagship products, including the new 5-liter oxygen concentrator, VPSA oxygen concentrator, 10-liter oxygen concentrator, portable oxygen concentrator, and the CV02 in-vehicle oxygen concentrator designed specifically for mobile scenarios. This comprehensive product line fully addresses multi-level respiratory health needs, ranging from home oxygen therapy to outdoor and in-vehicle use.

During the exhibition, the Canta booth attracted visitors from Middle Eastern countries such as Saudi Arabia, the United Arab Emirates, and Qatar, as well as guests from around the world. Numerous medical equipment buyers and channel partners highly praised the outstanding performance of Canta's oxygenation equipment.

Continuous Technological Leadership, Market Recognition for the Entire Product Series

At the exhibition, Canta Medical fully demonstrated its technical strength and innovative capabilities in the field of oxygenation. Among these, the independently developed VPSA oxygen concentrator employs a three-stage oxygen generation technology— 'positive pressure adsorption, negative pressure desorption, and vacuum retention' —which not only significantly enhances oxygen production efficiency but also substantially reduces energy consumption and operational noise. This makes it particularly well-suited for medical settings in the Middle East, where there are high standards for continuous, quiet oxygen supply.

The new 5-liter oxygen concentrator, with its lightweight design, quiet operation, and easy maintenance, has become the preferred solution for home oxygen therapy; the portable oxygen concentrator and the CV02 in-vehicle oxygen concentrator, featuring compact designs, long battery life, and quick start-stop functionality, effectively meet diverse health needs for outdoor emergencies and on-the-go use.

In addition, Canta showcased its cutting-edge technological achievements in the field of hyperbaric oxygen chambers. Canta's hyperbaric oxygen chambers strictly adhere to medical pressure standards, operating within a pressure range of 1.5–1.99 ATA and utilizing a saturated oxygenation mode to effectively enhance the efficacy of oxygen therapy. Their structural pressure-bearing design, intelligent integrated control system, and numerous user-friendly features also drew many industry professionals to stop and engage in conversation.

Deepening International Cooperation, Explore a New Ecosystem for Respiratory Health

MEDICA 2025 was not only a stage for Canta Medical to showcase its technological strength, but also an important opportunity to engage in in-depth exchanges and jointly plan for development with global customers and partners. Through this exhibition, Canta Medical gained a deeper understanding of the changing demands and technological trends in the international market.

Through this exhibition, Canta not only showcased its innovative achievements in oxygen generation technology but also engaged in in-depth exchanges with medical partners from the Middle East, North Africa, and Europe. Exchanged views on topics such as home health management solutions and the development of emergency medical systems, leading to the preliminary establishment of multiple cooperation agreements.

One attendee remarked, "Canta's oxygen concentrators are impressive in terms of performance stability and oxygen generation efficiency; they align perfectly with the practical needs of our region."

As a company with over 20 years of dedicated expertise in the oxygen generation field, Canta has consistently driven product innovation through technological advancements and guided its R&D efforts by user needs. This exhibition not only showcased the development level of China’s medical manufacturing industry to the world, but also through exchanges with global partners, further clarified the direction for future technological development and market expansion.

Moving forward, Canta Medical will continue to deepen its corporate philosophy of “technological innovation and dedicated manufacturing,” actively pursuing innovation to provide reliable oxygen therapy solutions for users in diverse regions and scenarios worldwide, thereby bringing high-quality respiratory health services to a broader population.